Daewoong Pharmaceutical’s’Hoystar tablet’ approved for phase 3 clinical trials for COVID-19 prevention effect
Hanmi Pharm received FDA approval for Phase 2 clinical trials of two new drug candidates for rare diseases
The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical